/
Our Company Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world.
$48.31
$0.80 (-1.63%)
Price from 5 days ago
18.00% operating margin is respectable but not wide. ROIC at 9.00%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 19.9% YoY with margins expanding 2.5pp.
Even for strong businesses, today's 20x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
20.2x earnings, 20.8x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$20.61B
▲ +19.9% YoY
Net Income (TTM)
$3.56B
▲ +56.4% YoY
Op. Margin
18.40%
▲ +2.5pp YoY
ROIC
10.07%
▲ +2.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3.48B
▲ +38.3% YoY
Op. Cash Flow (TTM)
$4.34B
▲ +32.0% YoY
Net Debt
$9.58B
Cash & Equiv.
$1.45B
5Y CAGR: +15.2%
5Y CAGR: +26.4%
Continue Research